4 Insights on

• Reduced Lung Damage
• Increased IL-10 Production
• Reduced Mortality
• Reduced Bacterial Load in Lungs

10 Insights on

• Reduced Inflammation Levels
• Reduced Pathogen Growth
• Reduced Pathogen Infection
• Enhanced Antimicrobial Resistance
• Reduced Pathogen Adhesion
• Improved Gastrointestinal Survival
• Reduced Pathogenic Bacteria
• Reduced Exposure to Harmful Substances
• Increased Exopolysaccharide Production
• Reduced Toxicity from Sodium Dodecyl Sulfate

16 Insights on

• Improved NK-Cell Cytotoxicity
• Reduced Upper Respiratory Tract Infection Days
• Improved Immune Function
• Reduced Upper Respiratory Infections
• Improved Immune Cell Function
• Reduced Incidence of Upper Respiratory Tract Infections
• Reduced URTI Symptoms
• Increased IL-2 Secretion
• Unchanged Immune Function
• Reduced Upper Respiratory Tract Infection Severity
• Reduced Duration of Upper Respiratory Tract Infection
• Improved Regulatory T Cell Function
• No Change in Immune Outcomes
• Reduced Upper Respiratory Symptoms
• No Change in Immune Response
• Reduced Cold/Flu Severity

23 Insights on

• Increased Lactic Acid Bacteria Levels
• Increased Serum Lysozyme Activity
• Improved Apparent Digestibility of Crude Protein
• Improved Growth Performance
• Increased Superoxide Dismutase Activity
• Enhanced Immune Response
• Improved Feed Utilization
• Enhanced Growth Performance
• Increased Superoxide Dismutase Levels
• Increased Protease Activity
• Increased Plasma Total Protein
• Improved Alternative Complement Pathway Activity
• Increased Peroxidase Levels
• Increased Mucus Secretion
• Increased Hematocrit Levels
• Enhanced Antioxidant Capacity
• Increased Gut Lactic Acid Bacteria Count
• Increased Protein Digestibility
• Increased Intestinal Lactic Acid Bacteria Count
• Improved Plasma Total Protein
• Increased Complement Pathway Activity
• Increased Peroxidase Activity
• Improved Fish Chemical Composition

1 Insight on

• Reduced Hepatic Oxidative Stress

12 Insights on

• Reduced Severity of Necrotizing Enterocolitis
• Increased Late-Onset Sepsis Incidence
• Reduced Mortality Rate Before Discharge
• Prevention of Necrotising Enterocolitis
• Reduced Necrotising Enterocolitis
• Reduced Mortality Rate
• Reduced Incidence of Late-Onset Sepsis
• Incidence of Necrotizing Enterocolitis
• Reduced Mortality
• Reduced Incidence of Necrotizing Enterocolitis
• Incidence of Late-Onset Sepsis
• Increased Sepsis Incidence

3 Insights on

• Reduced Hypertension
• Improved Anticoagulatory Effects
• Reduced Toxicological Concern

2 Insights on

• Reduced Nosocomial Diarrhea Incidence
• Increased Adverse Effects

2 Insights on

• Improved Survival Rate
• Improved Gastrointestinal Survival

1 Insight on

• Reduced TNF Production

3 Insights on

• Enhanced Antimicrobial Resistance
• Improved Mucoadhesion
• Increased Lactobacilli Release

6 Insights on

• Reduced Incidence of Colon Cancer
• Increased Antioxidant Activity
• Enhanced Antioxidant Activity
• Selective Anti-Colon Cancer Activity
• Non-Toxicity to Normal Colon Cells
• No Significant Inhibition on Normal Cells

4 Insights on

• Improved Gut Health
• Reduced Incidence of Infant Botulism
• Necrotizing Enterocolitis in Preterm Neonates
• Asymptomatic Carrier Status

4 Insights on

• Increased Superoxide Dismutase Activity
• Increased Ferric Reducing Ability of Plasma
• Increased Catalase Activity
• Increased Glutathione Peroxidase Activity

7 Insights on

• Improved Quality of Life
• No Significant Safety Parameter Changes
• Reduced Disease Severity
• Reduced IBS Symptoms
• Reduced IBS Symptom Severity (Diarrhea-Predominant)
• Improved Quality of Life for IBS-D Patients
• Improved IBS Severity

4 Insights on

• Reduced Pathogen Colonization
• Reduced Anaerobic Gram-Negative Bacterial Counts
• Increased Total Anaerobic Gram-Positive Bacteria Counts
• Reduced Colonization by Diarrheagenic E. coli (EPEC)

7 Insights on

• Increased Anti-Inflammatory Cytokine Levels
• Reduced Pro-Inflammatory Cytokines
• Reduced Pro-inflammatory Cytokine Release
• Reduced Proinflammatory Cytokine Production
• Increased Production of Anti-inflammatory Cytokine IL-10
• Increased IL-10 Production
• Increased Anti-Inflammatory Cytokine IL-10

1 Insight on

• Alleviated Diarrhea

6 Insights on

• Increased Secretory IgA Level
• Reduced Frequency of Upper Respiratory Tract Infections
• Increased Secretory Immunoglobulin A
• Increased Salivary IgA Levels
• Increased Salivary Secretory Immunoglobulin A Levels
• No Significant Reduction in CID Symptoms

11 Insights on

• Reduced Diarrhea Incidence
• Reduced Diarrhea Rate
• Reduced Vomiting Incidence
• Reduced Diarrhea Symptoms
• Reduced Abdominal Cramping
• Improved Overall Symptom Score
• Reduced Vomiting Symptoms
• Reduced Symptom Severity
• Reduced Overall Symptoms
• Improved Symptom Relief for Lactose Intolerance
• Reduced Vomiting

6 Insights on

• Improved Survival Rate
• Improved Intestinal Mucosal Immunity
• Enhanced Disease Resistance
• Enhanced Resistance to Edwardsiella tarda
• Improved Health Condition
• Improved Systemic Immunity

2 Insights on

• Reduced Staphylococcus Load in Breast Milk
• Reduced Breast Pain

4 Insights on

• Improved Intestinal Mucosal Immunity
• Improved Growth Performance
• Reduced Cumulative Mortality
• Reduced Streptococcus agalactiae Growth

16 Insights on

• Improved Gut Microbiota
• Improved Gut Microbiota Composition
• Reduced Pathogen Growth
• Reduced Pathogenic Load
• Reduced Candida albicans Colonization
• Increased Beneficial Gut Bacteria
• Reduced Pathogen Activity
• Enhanced Bile Salt Resistance
• Increased Survival in Acidic Environment
• Enhanced Intestinal Epithelial Cell Adhesion
• Reduced Pathogen Colonization
• Reduced Colonization of C. albicans in Intestines Post-Infection
• Increased Intestinal Cell Adhesion
• Reduced Pathogenic Microorganism Activity
• Increased Population of Beneficial Gut Bacteria
• Reduced Intestinal Colonization of Candida albicans

4 Insights on

• Improved Antioxidant Activity
• Enhanced Antioxidant Activity
• Increased Production of ACE-Inhibitory Peptides
• Reduced ACE Activity

2 Insights on

• Enhanced IFN-γ Production
• Enhanced Immunity to Intestinal Infections

5 Insights on

• Reduced Hospitalization Duration
• Reduced Pediatric Intensive Care Unit Stay
• Reduced Urinary Tract Infection Incidence
• Reduced Intra-Abdominal Infections
• Reduced Duration of Antibiotic Usage

4 Insights on

• Improved Immune Function
• Improved Phagocytic Activity of Macrophages
• Enhanced Immune Signaling Molecule Production
• Restored Immunological Function in Immunosuppressed Mice

4 Insights on

• Improved Gut Microbiota Composition
• Enhanced Resistance to Infections
• Increased Antibacterial Activity
• Enhanced Gastrointestinal Stress Resistance

2 Insights on

• Reduced Group B Streptococcus Colonization
• Reduced Vaginal Group B Streptococcus Colonization